GlassScriptPhysician profile
Michael D Karoly
NPI 1902895923
$1,926.83
in general payments reported to CMS, 2019-2025
25 companies · $69.00 in 2025
The $69.00 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $237 · 2021: $260 · 2022: $445 · 2023: $206 · 2024: $111 · 2025: $69.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $300.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $213.95 | 2019-2025 | |
| Abbvie INC. | $181.30 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $176.98 | 2022-2024 | |
| Hologic Sales and Service, LLC | $97.65 | 2020-2022 | |
| Evofem Biosciences, INC. | $95.97 | 2021-2025 | Solosec, Phexx, Phexxi |
| Therapeuticsmd, INC. | $88.83 | 2021-2022 | |
| Medtronic USA, INC. | $86.76 | 2019 | |
| Daiichi Sankyo INC. | $78.94 | 2022 | |
| Lupin INC. | $76.28 | 2019-2021 | |
| Exeltis, USA INC. | $68.83 | 2019-2023 | Slynd |
| Pfizer INC. | $65.10 | 2023-2024 | |
| Astellas Pharma US INC | $62.68 | 2024-2025 | Veozah |
| Scynexis, INC. | $59.99 | 2022 | |
| Amag Pharmaceuticals, INC. | $55.35 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $45.89 | 2021-2023 | Balcoltra |
| Vertical Pharmaceuticals, LLC | $29.86 | 2019 | |
| Mylan Pharmaceuticals INC. | $28.12 | 2021 | |
| Dysis Medical, INC. | $23.94 | 2021 | |
| Amgen INC. | $16.94 | 2023 | Prolia, Evenity |
| Millicent US INC | $15.79 | 2020 | |
| Coopersurgical, INC. | $15.00 | 2020 | |
| Merck Sharp & Dohme LLC | $14.29 | 2020 | |
| Channel Medsystems, INC. | $14.22 | 2023 | |
| Duchesnay USA Incorporated | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Karoly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.